The Chemical Loophole Telehealth Providers Need to Know About
The DEA has published its latest batch of exempt chemical preparation decisions. If your facility handles chemical preparations containing controlled substances for laboratory or research purposes, this notice applies to you.
What the DEA Published
This Federal Register notice, published May 20, 2026, covers applications received by the DEA between July 1, 2025, and March 31, 2026. The DEA reviewed each application and issued approvals or denials for exempt status under the Controlled Substances Act. Comment period closes July 20, 2026.
Who This Affects
This is not a general pharmacy or telehealth notice. It applies specifically to chemical manufacturers, reference standard suppliers, and research laboratories that handle controlled substance preparations for testing, calibration, or research purposes. If your facility applies for exempt chemical preparation status, this order may reference your products directly.
Why Exempt Status Matters
Exempt status removes certain CSA obligations — registration, recordkeeping, and reporting requirements — for qualifying preparations. Lose that status and those obligations come back immediately. The DEA can modify or revoke exemptions at any time. Assumptions are not a compliance strategy.
What You Should Do Now
If your facility handles chemical preparations containing List I or List II chemicals:
- Check whether your preparations appear in this notice — approved or denied.
- Review the full order for any corrections to previously published listings.
- Submit written comments by July 20, 2026 if you have objections to any decision.
- Consult your regulatory counsel if your exempt status is in question.
Source
Federal Register Notice, May 20, 2026: Exempt Chemical Preparations Under the Controlled Substances Act
This post is for educational purposes only and does not constitute legal or compliance advice. Consult a qualified attorney or compliance professional before acting on this information.
